Confirmatory factor analysis of the Pittsburgh Sleep Quality Index in women with hot flashes by Otte, Julie L. et al.
Confirmatory Factor Analysis of the Pittsburgh Sleep Quality 
Index in Women with Hot Flashes
Julie L. Otte, PhD, RN, Kevin L. Rand, PhD, Carol A. Landis, PhD, RN, FAAN, Misti L. 
Paudel, PhD, Katherine M. Newton, PhD, Nancy Woods, PhD, RN, FAAN, and Janet S. 
Carpenter, PhD, RN, FAAN
School of Nursing Indiana University, Indianapolis, IN (Otte, Carpenter); Department of 
Psychology, Indiana University-Purdue University, Indianapolis, IN (Rand); University of 
Washington School of Nursing (Landis and Woods); University of Minnesota School of Public 
Health and Epidemiology (Paudel); Harvard Medical School, Boston, MA; Group Health Research 
Institute, Seattle, WA (Newton)
Abstract
Objective—Women report poor sleep quality during various stages of the menopause transition 
and post-menopause, especially those with hot flashes. Sleep measurements vary widely due to the 
copious instruments available. The Pittsburgh Sleep Quality Index (PSQI) is a frequently used 
questionnaire that produces a single score for sleep quality. This one-factor structure has not 
received consistent support in the literature. The goal of this analysis was to determine the best 
factor structure of the PSQI in women with hot flashes.
Methods—A confirmatory factor analysis was conducted on the PSQI baseline data from three 
randomized controlled clinical trials enrolling peri- and postmenopausal women with hot flashes 
(N=849) from the Menopause Strategies: Finding Lasting Answers for Symptoms and Health 
(MsFLASH) network. Several a priori factor models were compared.
Results—One- and two-factor models did not fit the data. A three-factor model comprising Sleep 
Efficiency, Perceived Sleep Quality, and Daily Disturbance showed good fit; however, the sleep 
medication item was dropped due to poor fit and low rates of sleep medication use. The three-
factor model was examined in African American (AA) and Caucasian subsamples and found to be 
similar in both groups; however, two items showed small group differences in strength as 
indicators.
Conclusions—Sleep quality in midlife women with hot flashes, as measured by the PSQI, 
appears to comprise three correlated factors. Minor measurement differences detected between 
groups are of research interest, but do not necessitate different scoring practices. Additional 
research is needed to further define sleep quality and its associations with health-related outcomes.
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Sleep complaints are twice as prevalent in women compared to men, and disturbed sleep 
contributes to daytime fatigue and poor quality of life.1 Women report poor sleep quality 
during various stages of the menopause transition and post-menopause. This is especially 
true for women experiencing hot flashes, which are prevalent in as many of 50% of women 
during the late menopause transition and 48% during early postmenopause.2
Selecting a measure of sleep to use in research studies largely depends on the research 
question(s). Current self-report sleep measures typically address single or combinations of 
sleep complaints, such as: (a) sleep duration or total sleep time; (b) sleep latency (minutes to 
fall asleep); (c) number and duration of nighttime awakenings; (d) quality of perceived 
sleep; (e) sleep efficiency (amount of time in bed spent asleep vs amount of time spent in 
bed); (f) sleep medication use, and (g) daytime dysfunction (daytime sleepiness, inability to 
function during the day, feeling tired or fatigued).3–5 Instruments address either a single or 
combination of the above aspects and are often specific to the overarching sleep problem 
being addressed. Recommendations have been made for the standardization of sleep 
measures in order to facilitate meta-analyses in research in patients with cancer and 
insomnia6, but a variety of instruments continue to be used.7
The Pittsburgh Sleep Quality Index (PSQI) is one of the most frequently used questionnaires 
for the assessment of self-reported sleep quality in studies of men and women with and 
without chronic illnesses.4,8 The PSQI was created to capture sleep quality in a sample of 
psychiatric patients. The original intent of the questionnaire was to: (a) create a reliable and 
valid standardized measure of sleep quality; (b) provide a tool to distinguish good versus 
poor sleep quality; (c) create a measure of sleep quality that was user friendly for patients, 
clinicians, and researchers to interpret; and (d) provide a clinical tool that assessed a list of 
sleep disturbances that impact sleep quality for psychiatric populations. The PSQI contains 7 
individual sub-scales and a single factor global score of > 5 representing poor overall sleep 
quality. The global score of the PSQI has been deemed a simple measure for use in clinical 
and research to identify good versus poor sleep. The PSQI single-factor based score for 
sleep quality has consistently reported acceptable reliability and validity in various 
populations9–12 and has been translated into several different languages.9
The single factor structure of the PSQI has been analyzed to understand if the global sleep 
quality score derived from all of the individual 7- subscale scores is the best representation 
of sleep quality. This research, conducted in various adult samples with (depression, breast 
cancer, post-renal transplantation, rheumatoid arthritis) and without chronic illnesses 
(community dwelling English and Spanish men and women, Nigerian students, non-
depressed men and women), has yielded inconsistent results.13–18 Of seven studies, four 
found that a model comprising three factors (e.g. Sleep Efficiency, Perceived Sleep Quality, 
and Daytime Functioning) was a better fit to the data than a 1-factor global score for sleep 
quality.13–16 One study found a 1-factor model (Sleep Quality)19 and two studies reported 2-
factor models (Sleep Efficiency, Perceived Sleep Quality) were most appropriate for the 
populations being studied.17,18 The Otte et al. study also found racial differences in a nested-
model comparison of African American and Caucasian breast cancer survivors of Sleep 
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Quality and Sleep Latency as well as Sleep Efficiency and Sleep Quality.18 The findings 
from these studies raise questions about whether it is appropriate to use a single global score 
to differentiate good from poor sleep quality across clinical populations. There were several 
limitations to these previous studies that make it difficult to generalize the findings of sleep 
quality to other populations, such as women with hot flashes. These include sample 
heterogeneity (mixed gender, wide age ranges and specific focus on chronic illnesses) and 
varied sample sizes from 107 to 1174.18 There have been no multi-group analyses using 
factor modeling to determine if mixed sample groups limit the factor findings.15 In addition, 
findings have been limited to research studies and it is unclear how findings can be 
translated into clinical practice.
Since sleep is a significant problem in women during the menopause transition, it would be 
informative to evaluate whether the single factor measure from the PSQI compared to the 
previously reported Otte et al. 2-factor model and Cole et al. 3-factor models best reflects 
good versus poor sleep quality in a large sample of relatively healthy midlife women in late 
perimenopause and early post-menopause with hot flashes.13–15 Additional nested model 
comparisons between African American and Caucasian women can identify potential racial 
differences which have been reported in a previous study of women with breast cancer.18 
The goal of this analysis is to provide recommendations on the best factor structure of the 
PSQI to analyze sleep quality in research trials of women with hot flashes.
METHODS
Procedures
Baseline data from the PSQI were pooled from three samples of midlife women 
participating in Menopause Strategies: Finding Lasting Answers for Symptoms and Health 
(MsFLASH) controlled randomized trials. Study 1 was a randomized control trial of 
escitalopram versus placebo for the treatment of hot flashes.20–22 Study 2 was a 3 by 2 
factorial design study that yielded 3comparison groups: (a) yoga versus usual activity; (b) 
exercise versus usual activity; and (c) omega 3 fatty acids versus placebo pill for hot 
flashes.23–26 Study 3 was a randomized control trial of low-dose estradiol versus placebo 
and venlafaxine XR versus placebo for menopausal symptoms.27 Data from a total of 899 
midlife women from these 3 studies were evaluated (study 1 n = 205, study 2 n = 355, study 
3 n = 339). Descriptions of the procedures used in the MsFLASH trials have been published 
elsewhere.20–27
Setting
Participants were recruited from five MsFLASH network sites (Seattle, Boston, Oakland, 
Indianapolis, and Philadelphia). Participants were recruited from July 2009 to October 2012 
through targeted mailings to midlife aged-women using purchased mailing lists.
Measures
Sample characteristics were collected using an adapted multi-item questionnaire that 
included items from the PSQI and also measured race, age, marital status, educational and 
income level, employment status, height, and weight.
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Sleep was assessed using the PSQI,4 a 19-item scale that provides 7 component scores 
(ranges 0–3): sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep 
disturbance, use of sleep medications, and daytime dysfunction. The 7 component scores are 
combined to produce a global sleep quality index score. The global scores range from 0–21, 
with scores above 5 reflecting poor global sleep quality4 and scores above 8 reflecting poor 
sleep and high daytime fatigue burden.9
Statistical Analysis
In order to determine the best factor model and scoring method for the PSQI among women 
with hot flashes, a confirmatory factor analysis using LISREL 8.828 was conducted. Because 
the single global score of the PSQI is frequently used in the literature, we examined the fit of 
a 1-factor model. Because recent studies (Cole et al.15 and Otte et al.18) found support both 
for 2-factor and 3-factor models, we examined the fit of these models in the present sample. 
Given that parsimonious models are preferred to more complex ones, we examined these 
models in order of increasing complexity.
The subscale scores from the 7 PSQI components represent ordinal rather than continuous 
data and should not be analyzed using methods that assume they are continuous variables 
with metric properties.29 Instead, PRELIS 2.828 was used to estimate the polychoric 
correlations among the subscale scores.29 Polychoric correlations are used to describe the 
associations between observed ordinal variables (i.e., PSQI subscale scores) that represent 
underlying phenomena (i.e., sleep characteristics) that are normally distributed and 
continuous. These polychoric correlations were then used to create an asymptotic covariance 
matrix (similar to a correlation matrix) that represents all of the inter-relationships among 
the PSQI subscales. It is this matrix of associations among the PSQI subscales that was used 
to examine the various factor models (using the weighted least squares approach).
The appropriateness of a factor model is evaluated based on how well the theoretical model 
fits the observed matrix of associations. Several indices have been developed to describe 
model fit, with each index using different criteria.30 We chose three of the most commonly-
used fit indices: (a) chi-square (χ2); (b) the Root Mean Square Error of Approximation 
(RMSEA) and its 90% confidence interval; and (c) the Comparative Fit Index (CFI). The χ2 
is an index of absolute fit between the hypothesized and observed covariance matrices. A 
non-significant χ2 is evidence of acceptable fit. The RMSEA is a parsimonious index, 
meaning that the complexity of the hypothesized model is taken into consideration in 
evaluating its fit with the observed covariance matrix. RMSEA values ≤ .06 indicate 
acceptable fit.30 The CFI is an incremental fit index, with values ≥ .95 indicating acceptable 
fit.30
Once the best-fitting model has been determined in the overall sample, its consistency across 
subsamples can be examined using nested-model comparisons. Such comparisons involve 
statistically comparing different parameters of the model to find which ones are significantly 
different in one group versus the other.
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The majority of the women were non-Hispanic (97.2%), Caucasian (59.0%), partnered 
(63.2%), employed (69.7%), and highly-educated (79.6% with some college). A substantial 
portion of the sample was African American (33.8%), with smaller proportions of American 
Indian (1.2%), Asian/Pacific Islander (2.2%), and women who self-identified as “Other” 
(2.8%). The mean age was 54.47 years (SD = 3.83). The mean global PSQI score was 7.82 
(SD = 3.47). The majority of women (72.0%) had global scores above the cutoff score of 5, 
suggesting poor sleep quality, and a sizeable portion of those women (39.8%) had scores >8 
indicating poor sleep quality and high fatigue burden.
Responses to the PSQI were scored into the seven subscales4 and 94.4% of the sample had 
complete baseline data on all component scores. The means, standard deviations, and 
correlations among the subscales are shown in Table 1. The number of missing values for 
each subscale ranged from 7 to 17, with a total of 50 participants missing data on at least one 
subscale. None of the cases with missing values had adequate information to allow for 
imputation. Therefore, these 50 cases were excluded from the confirmatory factor analysis, 
resulting in a final sample size of 849. We compared women with complete data to women 
with missing data and found that there were no differences on age (M = 54.48 & 54.16 for 
complete and missing data respectively). There was a small, but significant relationship 
between education and missing data points; women with less education were more likely to 
have missing data, rs = −.078, p = 0.019. There also was a relationship between race/
ethnicity and missing data, χ2(5) = 19.04, p = .002; specifically, proportionately more 
African American women had missing data compared to Caucasian women (7.89% vs. 
2.19%, respectively). Similarly, never married women had proportionately more missing 
data than women who were married or divorced/separated (8.47% vs. 3.40% & 2.16%, 
respectively, χ2(4) = 9.51, p = .049). This could be attributed to women without bed partners 
not providing a response for the bed partner related item.
Confirmatory factor analysis
The sample sizes, means, standard deviations, and correlations among the seven PSQI 
subscales are shown in Table 1. Univariate skew and kurtosis statistics were examined for 
each component score and none of the indicators showed excessive skew or kurtosis.31 
Hence, none of the data were transformed. The fit indices for the tested models are shown in 
Table 2. The 1-factor model (Model 1), consistent with the global score of the PSQI, did not 
show acceptable fit on any of the indices. The 2-factor model (Sleep Efficiency, Perceived 
Sleep Quality) (Model 2)15 also did not show acceptable fit on any index. A modified 2-
factor model (Model 3)18 showed better fit, with the CFI indicating acceptable fit. The 3-
factor model (Sleep Efficiency, Perceived Sleep Quality; Daily Disturbances) (Model 4)15 
showed the best fit, with acceptable values on the RMSEA and CFI.
The 3-factor model (Model4)15 is presented in Figure 1 with its standardized coefficients. 
As the model shows, the loading from Perceived Sleep Quality to the sleep medication use 
subscale is small (β = .15), which leaves a large amount of unexplained variability in this 
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item (δ = .98). The small loading of the sleep medication use item is consistent with its weak 
correlation with the other subscales of the PSQI (Table 1). As the correlation table shows, 
even the strongest association of sleep medication use with sleep latency was small (r = .15). 
This is likely due to a restriction of range, as 68% of the sample reported using no sleep 
medication at all.
Given the low rate of sleep medication use and the resultant weak correlations between it 
and the other PSQI subscales, we examined an alternative 4-factor model where Sleep 
Medication Use was modeled as a separate factor along with Perceived Sleep Quality, Sleep 
Efficiency, and Daily Disturbance. This model showed good fit to the data (Model 5 in 
Table 2). However, the Sleep Medication Use factor did not correlate strongly with any of 
the other factors (ψ = .03-.18), which raises the question of utility of this item in assessing 
sleep quality among women with hot flashes.
Consequently, we examined the fit of an alternative 3-factor model (Sleep Efficiency, 
Perceived Sleep Quality, and Daily Disturbance), excluding the sleep medication use item, 
and this model showed good fit to the data across all indices, including a non-significant χ2 
(Table 2; Model 6). Therefore, we concluded that this 3-factor conceptualization represented 
the best model of sleep quality among women with hot flashes (see Figure 2).
To examine whether the factor structure was consistent between African American and 
Caucasian subsamples, we conducted several two-group comparisons. Although the sample 
consisted of women from several racial/ethnic groups, only the African American (n = 304) 
and Caucasian (n = 530) subsamples had sufficient numbers to allow for statistical 
comparisons of the factor models. First, a two-group, 3-factor model was examined with all 
parameters freed to vary between groups. This model showed good fit to the data across all 
indices (Table 2; Model 6a). We constrained the factor loadings to be equal across both 
groups, and the resulting 3-factor model showed significantly worse fit to the data, Δχ2 (df = 6) = 23.81, p = 0.0005, indicating that the factor loadings differed between African American and Caucasian women.
Subsequently, we conducted a series of nested-model comparisons to determine which 
factor loadings onto the PSQI subscales differed between the two groups (Table 3). The 
loading values for the Perceived Sleep Quality factor onto the subjective sleep quality 
subscale differed significantly between groups, with standardized loadings of .72 and .87 for 
Caucasian and African American women, respectively. This suggests that subjective sleep 
quality subscale is a slightly stronger indicator of Perceived Sleep Quality factor in African 
American women compared to Caucasian women. In addition, the loading values for the 
Sleep Efficiency factor onto the habitual sleep efficiency subscale differed significantly 
between groups, with standardized loadings of .73 and .44 for Caucasian and African 
American women, respectively.. This indicates that among menopausal women, habitual 
sleep efficiency subscale is a stronger indicator of Sleep Efficiency factor for Caucasian 
women compared to African American women. Although we were able to detect two 
differences in the factor loadings of African American compared to Caucasian women, these 
results do not require different PSQI scoring procedures for the two groups. For both groups 
of women, subjective sleep quality and habitual sleep efficiency are reliable, positive 
indicators of their respective constructs. These loading differences may indicate subtle 
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cultural differences in expectations or habitual practices with regard to sleep and sleep-
related behaviors.
However, these differences are mainly of interest for research purposes and do not 
necessitate different scoring procedures for African American versus Caucasian women.
Next, we constrained the correlations among the three factors to be equal between groups to 
test if the factor intercorrelations differed in African American and Caucasian women. The 
resulting model showed no significant difference in fit, Δχ2 (df = 3) = 5.34, p = 0.1485, 
indicating that the correlations among Sleep Efficiency, Perceived Sleep Quality, and Daily 
Disturbance were the same in African American and Caucasian women. This result suggests 
that the structure of sleep quality is similar in African American and Caucasian women with 
hot flashes and that the pattern of relationships among the factors is the same for both 
groups. Taken together, these results suggest that the three-factor model is the best 
conceptualization of the PSQI among women with hot flashes and that there are no major 
racial differences.
DISCUSSION
The results of this study showed that sleep quality, as measured by the PSQI, in midlife 
women in the late menopause transition and early postmenopause with daily hot flashes is 
multifaceted with three correlated factors: Sleep Efficiency, Perceived Sleep Quality, and 
Daily Disturbance. This 3-factor model fit well in both African American and Caucasian 
subsamples and the correlations among the factors were equivalent across the two groups. 
This finding suggests that from a practical perspective, the structure of sleep quality, at least 
as measured by the PSQI, is consistent in African American and Caucasian women.
Overall, results of these analyses in midlife women with hot flashes are consistent with 
previous reports analyzing a three-, two- and one factor models of sleep quality. The nested 
model comparisons by race show no major differences as with the previous Otte et al. 
study.18 The model results are similar to previous factor analyses that also found that a 3-
factor model (Sleep Efficiency, Perceived Sleep Quality, Daily Disturbances) best fit the 
data in depressed and non-depressed adults,15 520 Nigerian university students,13 135 post-
renal transplant patients,14 and 3,667 community-dwelling English and Spanish speaking 
Hispanic and non-Hispanic adults.16 Conversely, the traditional 1-factor (Sleep Quality) and 
2-factor models (Sleep Efficiency; Perceived Sleep Quality) consisted of samples of 197 
Chinese women with breast cancer,19 417 depressed and non-depressed older adults,15 107 
patients with rheumatoid arthritis,17 and 1174 non-depressed breast cancer survivors.18 Two 
of the prior studies also produced a better model fit by removing the sleep medication item 
during the analysis.16,17 The findings from these various studies show that the PSQI factor 
structure differ among studies that have different mixed genders, race, and chronic illnesses. 
Differences in factor structure can also be attributed to the wide range of sample sizes 
among the studies, which can impact factor structure. The result of this variability in 
samples and factor structures suggests future research studies should consider how the PSQI 
should best be analyzed in light of these findings. The results also suggest that when 
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evaluating intervention efficacy using the PSQI using different factor structure can delineate 
improvements in more specific areas such as sleep efficiency or perceived sleep quality.
Although we found that the factor structure and factor inter-correlations were consistent 
between African American and Caucasian women, nested model comparisons did reveal two 
measurement differences. First, we found that the subjective sleep quality subscale was a 
stronger indicator of Perceived Sleep Quality factor in African American women compared 
to Caucasian women. This difference is important from a measurement and research 
standpoint. However, it is unlikely to be of any practical or clinical significance.32 For both 
African American and Caucasian women, subjective sleep quality is the best indicator of 
Perceived Sleep Quality. Second, we found that assessing the Sleep Efficiency factor 
differed significantly in African American versus Caucasian women. Specifically, we found 
that Sleep Efficiency among African American women was primarily captured by the sleep 
duration subscore. In contrast, the habitual sleep efficiency subscale was a stronger indicator 
of Sleep Efficiency in Caucasian versus African American women. This could mean that 
African Americans with poor sleep efficiency have shorter sleep duration. Again, this 
difference is important from a research and measurement perspective, but is unlikely to 
matter in the clinical assessment of sleep quality.
Our results suggest that the sleep medication item may not be a good indicator of sleep 
quality among women participating in clinical trials for hot flashes, likely due to low use of 
sleep medication in this population. This is a consistent finding across the multifactor model 
analyses. In the present sample, 68% of women reported not using any sleep medications at 
all. Sleep medication use may be an indicator of sleep quality among older women or those 
being treated for illnesses (e.g., breast cancer), as they may be more likely to take 
medications to improve different aspects of quality of life. Further research is needed to 
determine what factors drive the use of medications to help with sleep among women. 
Although it is clinically important to query patients regarding sleep medication use, it is 
recommended that the item be removed from the PSQI sub-scale scoring until further 
validity and reliability testing is performed.
The results from this study and the previous factor analyses highlight the fact that the 
definition of sleep quality varies among researchers, clinicians and patients resulting in a 
poorly defined concept.32 The concept of perceived sleep quality tends to have a single 
meaning based on subjective criteria as a way to interpret the overall perception of an 
individual’s sleep. A qualitative study of adults with and without insomnia found that 
perceived sleep quality is a multifaceted concept that includes: (a) being tired upon waking 
that lasts throughout the day; (b) the feeling of being rested upon waking; and (c) number of 
awakenings during the night of sleep.32 It could be suggested that assessing patient’s sleep 
quality requires appraisal of sleep as a continuous assessment of multiple factors and cannot 
be distilled into a single factor concept as in the PSQI. However, the data findings in this 
analysis are limited to women in late menopause transition and early postmenopausal 
experiencing hot flashes limiting generalizability to all midlife women of this age range and 
menopausal status.
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Because of the wide range of research instruments used to measure the different aspects of 
self-reported sleep, it is challenging to aggregate findings across studies to compare the 
incidence and prevalence of sleep complaints. This is especially true in women who 
continue to remain underrepresented in sleep research.1 The PSQI, as a measure of sleep 
quality, is sensitive to race, ethnicity, chronic illness, and gender, making cross-study 
comparisons of sleep a continued challenge.
Based on the results of this study, alternative PSQI scoring could be considered and further 
evaluated using the 3-factor model for self-reported sleep in studies of midlife women with 
hot flashes. Revisions would consist of recalculations of subscale loadings into Sleep 
Efficiency (sleep disturbance and habitual sleep efficiency subscale), Perceived Sleep 
Quality (subjective sleep quality and sleep latency subscales, and Daily Disturbance (sleep 
disturbance and daytime dysfunction subscale). There is also the issue of how sleep quality 
is defined and the problem with a single score reflecting a complex concept. Further work is 
needed to address this issue for measuring sleep quality. Improving understanding of the 
larger concept of sleep quality can further research efforts to facilitate better subjective 
measurement that can be used for intervention testing that can improve sleep for women 
during the menopause transition.
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3-Factor Model of Sleep Quality Measured with the Pittsburgh Sleep Quality Index in 
Midlife Women15
Note: All coefficients are standardized and significant at p < .05, unless otherwise noted.
Ovals = latent variables. Rectangles = measured variables. Single-headed arrows = factor 
loadings. Double-headed arrows = correlations; Italicized coefficients are error terms, 
representing the proportion of variation in the variable not accounted for by the model.
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Alternative 3-Factor Model of Sleep Quality Measured with the Pittsburgh Sleep Quality 
Index in Midlife Women without Sleep Medication Use Item
Note: All coefficients are standardized and significant at p < .05, unless otherwise noted.
Ovals = latent variables. Rectangles = measured variables. Single-headed arrows = factor 
loadings. Double-headed arrows = correlations; Italicized coefficients are error terms, 
representing the proportion of variation in the variable not accounted for by the model; † = 
Parameters were found to differ significantly between African American and Caucasian 
subsamples. A = parameter estimate for African American subsample; C = parameter 
estimate for Caucasian subsample.
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